Novotech News

  1. Novotech Identifies Decentralized Clinical Trials Potential And Challenges For Accelerating Global Biotech Clinical Trials In 2024 11/27/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, will be presenting at the Clinical Research Governance (CRGo) World Conference & International Clinical Trial Center Network (ICN) Symposium 2023 in Hong Kong this month.

  2. Novotech Publishes New Reports On Dyslipidaemia And Non-Small Cell Lung Cancer Global Clinical Trial Landscape 11/22/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today released the latest 2023 global clinical trial landscape reports on dyslipidaemia and non-small cell lung cancer (NSCLC).

  3. Novotech Publishes Whitepaper On Infectious Diseases Clinical Trials, Revealing Over 7,000 Trials Launched Worldwide 11/8/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today published the latest 2023 global clinical trial environment whitepaper focused on infectious diseases.

  4. Novotech Opens ChinaTrials 15 Conference With Workshop On How Biotechs Can Accelerate Global Trials 11/7/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, opens the ChinaTrials 15 conference in Shanghai, China with a message to China biotechs about the benefits of conducting simultaneous China, US and Australia trials to accelerate drug development.

  5. Driving Progress Towards Gender Equality And Inclusion 11/6/2023

    At Novotech, we are dedicated to fostering a diverse, equitable and inclusive workplace where all employees, regardless of gender, feel valued, respected and supported.

  6. Novotech Releases In-Depth 2023 Global Clinical Trial Landscape Reports On Hemophilia And Primary Biliary Cholangitis 11/6/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today released the latest 2023 global clinical trial landscape reports on Primary Biliary Cholangitis (PBC) and Hemophilia.

  7. Novotech Announces Key Leadership Appointments: Rick Farris, North America Managing Director And Dr. David Ng, Global Vice President Of Biometrics And Data 10/13/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announces significant senior executive hires to further expand services for Novotech’s global biotech clients.

  8. Dr. Yooni Kim, Vice President Of Clinical Services At Novotech, Delivers Keynote Address At Veeva Korea Summit 10/12/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announced today that Dr. Yooni Kim, Vice President of Clinical Services at Novotech, served as a keynote speaker at the Veeva Korea Summit this week in Seoul, Korea.

  9. Novotech Secures Consecutive Frost & Sullivan CRO Company Of The Year Award 10/11/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, has been selected as the CRO Company of the Year 2023 by growth advisory and opportunity analytics firm Frost & Sullivan. Novotech has been a recipient of the Frost & Sullivan Best Practices awards since 2006.

  10. Novotech Appoints Dr. Judith Ng-Cashin As Chief Medical Officer To Drive Global Medical Services 10/5/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announced today the appointment of Dr. Judith Ng-Cashin as Chief Medical Officer (CMO).